Welcome to our dedicated page for Transdigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TransDigm Group Incorporated filings document operating results, material events and capital-structure activity for an aerospace components company listed on the New York Stock Exchange under TDG. Form 8-K reports include quarterly financial results, conference-call materials, acquisition-related events and exhibits furnished with company press releases.
The filing record also covers financing arrangements at subsidiary TransDigm Inc., including senior subordinated notes, term loans, indenture and guarantee disclosures. Governance filings report annual meeting voting outcomes, director elections, auditor ratification and advisory executive-compensation votes, alongside common-stock registration details and other material agreements.
TransDigm Group (TDG) furnished its quarterly results update. The company furnished a press release announcing financial results for its fourth quarter ended September 30, 2025, as Exhibit 99.1. The information is furnished and, as stated, is not deemed “filed” for liability purposes and is not incorporated by reference into other filings.
TransDigm will host a conference call on November 12, 2025 at 11:00 a.m. Eastern Time. A live audio webcast and slide presentation will be available at https://www.transdigm.com via the investor relations page under “Presentations,” with a replay archived later that day.
TransDigm Group (TDG) reported that director David Barr acquired 518 stock options on 11/04/2025 (transaction code A) with an exercise price of $1,291.97 per share. The options expire 11/04/2035 and vest 20% per year over five years beginning September 30, 2026, subject to achieving annual operating performance targets. Following the transaction, 518 derivative securities were beneficially owned, held directly.
TransDigm Group (TDG) filed a Form 4 for director Jane Cronin reporting a grant of stock options on 11/04/2025. The award covers 518 options with an exercise price of $1,291.97 per share.
The options vest 20% per year over five years beginning September 30, 2026, subject to the achievement of annual operating performance targets, and expire on 11/04/2035. Following this transaction, 518 derivative securities were beneficially owned, held directly.
TransDigm Group (TDG) reported a Form 4 for a director, reflecting a grant of stock options for 518 shares on November 4, 2025 with an exercise price of $1,291.97 per share and an expiration date of November 4, 2035.
The options vest at 20% per year over five years beginning September 30, 2026, subject to the achievement of annual operating performance targets. Following the grant, the reporting person held 518 derivative securities directly. The derivative security is a stock option on TransDigm common stock.
TransDigm Group (TDG) director Sean Hennessy reported a grant of 518 stock options on 11/04/2025 at an exercise price of $1,291.97 per share. The options vest 20% per year over five years beginning September 30, 2026, subject to annual operating performance targets, and expire on 11/04/2035. Following the grant, Hennessy beneficially owns 518 derivative securities, held directly.
TransDigm Group (TDG) reported an insider equity grant. Director W. Nicholas Howley received 518 stock options on 11/04/2025 at an exercise price of $1,291.97 per share. The options vest 20% per year over five years beginning September 30, 2026, subject to the achievement of annual operating performance targets, and expire on 11/04/2035. Following the grant, 518 derivative securities were beneficially owned directly.
TransDigm Group (TDG) — Form 4: Director Gary McCullough reported a grant of stock options on 11/04/2025. The award covers 518 options to purchase common stock at an exercise price of $1,291.97 per share, expiring on 11/04/2035. The filing lists 518 derivative securities beneficially owned following the transaction, held direct.
Per the footnote, the options vest 20% per year over five years beginning September 30, 2026, and are subject to annual operating performance targets.
TransDigm Group (TDG): Director Peter Palmer reported an equity grant on Form 4. He acquired stock options covering 518 shares on Nov 4, 2025 with an exercise price of $1,291.97 per share and an expiration date of Nov 4, 2035.
The options vest at 20% per year over five years, beginning Sept 30, 2026, and are subject to the achievement of annual operating performance targets each year. Following the transaction, 518 derivative securities were beneficially owned on a direct basis.
TransDigm Group (TDG) filed a Form 4 showing a director stock option grant. On 11/04/2025, a reporting person serving as a Director received stock options covering 518 shares at an exercise price of $1,291.97 per share. The options were reported as acquired (Code A) and are held directly.
The options expire on 11/04/2035 and vest at 20% per year over five years beginning September 30, 2026, subject to the achievement of annual operating performance targets in each year.
TransDigm Group (TDG) reported that director Robert Small acquired 518 stock options on November 4, 2025 (Transaction Code A) with an exercise price of $1,291.97 per share and an expiration date of November 4, 2035.
The options vest at 20% per year over five years beginning September 30, 2026, subject to the achievement of annual operating performance targets. Following the transaction, 518 derivative securities were beneficially owned, held directly.